Qube Research & Technologies (QRT)
SQZ

Qube Research & Technologies (QRT)’s SQZ Biotechnologies Company SQZ Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,679
Closed -$40K – 3159
2022
Q3 		$40K Sell
17,679
-2,223
-11% -$6.67K ﹤0.01% 2189
2022
Q2 		$63K Buy
+19,902
New +$71.6K ﹤0.01% 2076

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SQZ Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 17,679 shares — an estimated $40K sold.

Qube Research & Technologies (QRT) first reported a position in SQZ in Q2 2022 and held it in 2 quarters. The position peaked at $63K in Q2 2022. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 17,679 SQZ Biotechnologies Company shares in Q4 2022, an estimated $40K.
  • Qube Research & Technologies (QRT) first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s SQZ Biotechnologies Company position peaked at $63K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.